SPY317.59+3.21 1.02%
DIA260.82+3.58 1.39%
IXIC10,617.44+69.69 0.66%

Ladenburg Thalmann Initiates Coverage On Forte Biosciences with Buy Rating

Ladenburg Thalmann initiates coverage on Forte Biosciences (NASDAQ:FBRX) with a Buy rating.

Benzinga · -
Ladenburg Thalmann initiates coverage on Forte Biosciences (NASDAQ: FBRX) with a Buy rating.